Try it
Biochemistry · Nucleotide metabolism: activation of 6-mercaptopurine
Sample item6-Mercaptopurine is a prodrug. It inhibits de novo purine synthesis only after conversion to a thioinosine monophosphate nucleotide by an enzyme of the purine salvage pathway. A tumour that has lost this enzyme would be resistant. Which enzyme is this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Hypoxanthine-guanine phosphoribosyltransferase
HGPRT transfers ribose phosphate from PRPP onto mercaptopurine, forming thio-IMP. This nucleotide inhibits the committed enzyme glutamine-PRPP amidotransferase and the conversion of IMP to AMP and GMP, and it is incorporated into nucleic acids. Loss of HGPRT is a recognised cause of thiopurine resistance.
Option by option
A. Orotate phosphoribosyltransferase
This pyrimidine pathway enzyme acts on orotate, not on purine analogues.
B. Adenosine deaminase
Adenosine deaminase deaminates adenosine and deoxyadenosine and does not activate thiopurines.
C. Thiopurine methyltransferase
This methyltransferase inactivates the drug and would not be needed for activation.
D. Hypoxanthine-guanine phosphoribosyltransferase (correct)
Correct. Conversion to the nucleotide by the salvage transferase generates the active inhibitor.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…